Reaktion #77831

ord-84dfd74cbbff4318951d21d92992664f

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigewas quenched with NaHCO3 solution
  2. 2
    ExtraktionThis was extracted with EtOAc
  3. 3
    TrocknenThe EtOAc was dried
  4. 4
    Einengenconcentrated
  5. 5
    SonstigeReverse phase HPLC purification (gradient elution, water/acetonitrile/TFA) of the resulting residue

Vorschrift

The title benzamide from Example 1 (21 mg) was dissolved in THF prior to the addition of Hunigs's base (0.01 mL). Next, 37% formaldehyde (0.017 mL) was added along with 4A molecular sieves. After 3 h, NaHB(OAc)3 (38 mg) was added. This mixture was stirred an additional 2 h before the reaction was quenched with NaHCO3 solution. This was extracted with EtOAc. The EtOAc was dried and concentrated. Reverse phase HPLC purification (gradient elution, water/acetonitrile/TFA) of the resulting residue provided the title benzamide N-[2-[[(1S,2S)-2-[(4-chlorobenzyl)(methyl)amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide (10 mg). MS found: (M+H)+=482.3.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US06706712B2uspto-grants-2004_03